Bevacizumab recalls
The FDA has published 16 recalls involving Bevacizumab since 2013. The latest was reported on 15 Oct 2025. Most were for sterility. Pine Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls 16 since 2013
Last 12 months 0 reported
Class I 0 0% of total
Ongoing 0 latest 15 Oct 2025
Recalls per month, last 24 months click a bar for that month
Severity split
Class I 0 0% Class II 15 94% Class III 1 6%
Why bevacizumab is recalled
All bevacizumab recalls, newest first 16 total
Reported Class Recall Company Reason Where 15 Oct 2025 Drug CLASS II Bevacizumab 1.75 mg/ - syringe, Intravitreal Total Volume recalled RC Outsourcing Sterility Nationwide 25 Oct 2023 Drug CLASS II Bevacizumab 1.25 MG/ Solution for Injection syringes recalled Pine Pharmaceuticals Sterility Nationwide 19 Apr 2023 Drug CLASS III Bevacizumab 2.5 mg/, Solution for Injection recalled Pine Pharmaceuticals Packaging Defects Nationwide 18 Sep 2019 Drug CLASS II Bevacizumab, 1.25 mg/ MJ Syringe Intravitreal Injection recalled Pacifico National Sterility PR 18 Sep 2019 Drug CLASS II Bevacizumab, 2.5 mg/, Norm-Ject Syringe Intravitreal recalled Pacifico National Sterility PR 21 Aug 2019 Drug CLASS II Bevacizumab 784 MG / Ns Ivpb recalled by Infusion Options Infusion Options Sterility NY 5 Jun 2019 Drug CLASS II Bevacizumab 2.5 mg recalled by Avella of Deer Valley, Inc. Avella of Deer Valley Inc. Store 38 Sterility Nationwide 8 May 2019 Drug CLASS II Bevacizumab 1.25 mg/ MJ syringe Intravitreal Injection recalled Pacifico National Packaging Defects Nationwide 14 Nov 2018 Drug CLASS II Bevacizumab 2.5 MG/, pre-filled syringe recalled Avella of Deer Valley Inc. Store 38 Sterility Nationwide 27 Jan 2016 Drug CLASS II Bevacizumab 1.25 mg/ filled to in 5/16" Syringe recalled Pine Pharmaceuticals Particulate Matter Nationwide 27 Jan 2016 Drug CLASS II Bevacizumab 2.5 mg/ in 5/16" Syringe recalled by Pine Pharmaceuticals Pine Pharmaceuticals Particulate Matter Nationwide 27 Jan 2016 Drug CLASS II Bevacizumab 2 mg/ in 5/16" Syringe for intravitreal recalled Pine Pharmaceuticals Particulate Matter Nationwide 27 Jan 2016 Drug CLASS II Bevacizumab 1.25 mg/ in 5/16" Syringe recalled by Pine Pharmaceuticals Pine Pharmaceuticals Particulate Matter Nationwide 12 Nov 2014 Drug CLASS II Bevacizumab/Dexamethasone, Injectable plastic syringe, RX recalled Oregon Compounding Centers Sterility OR, WA 6 Nov 2013 Drug CLASS II Bevacizumab 25mg/mL, prepared as pre-filled syringes recalled Fallon Wellness Pharmacy Labeling Errors ME, NY 25 Sep 2013 Drug CLASS II Bevacizumab 1.25 mg/ PF, Avella Specialty Pharmacy, Phoenix recalled Avella of Deer Valley Sterility Nationwide
Should you stop taking Bevacizumab?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.